BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

741 related articles for article (PubMed ID: 19766887)

  • 1. Treatments for skin and soft-tissue and surgical site infections due to MDR Gram-positive bacteria.
    Stevens DL
    J Infect; 2009 Sep; 59 Suppl 1():S32-9. PubMed ID: 19766887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging issues in the diagnosis and management of infections caused by multi-drug-resistant, gram-positive cocci.
    Napolitano LM
    Surg Infect (Larchmt); 2005; 6 Suppl 2():S-5-22. PubMed ID: 23577494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and management of Staphylococcus aureus infections of the skin and soft tissue.
    Roberts S; Chambers S
    Intern Med J; 2005 Dec; 35 Suppl 2():S97-105. PubMed ID: 16271065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of primary care prescribers in the diagnosis and management of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
    Lawrence KR; Golik MV; Davidson L
    Am J Ther; 2009; 16(4):333-8. PubMed ID: 19617720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin and soft-tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus.
    Stryjewski ME; Chambers HF
    Clin Infect Dis; 2008 Jun; 46 Suppl 5():S368-77. PubMed ID: 18462092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin and soft-tissue infections: a critical review and the role of telavancin in their treatment.
    Cardona AF; Wilson SE
    Clin Infect Dis; 2015 Sep; 61 Suppl 2():S69-78. PubMed ID: 26316560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of the guidelines for complicated skin and soft tissue infections and intra-abdominal infections--are they applicable today?
    Caínzos M
    Clin Microbiol Infect; 2008 Dec; 14 Suppl 6():9-18. PubMed ID: 19040462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dalbavancin: a review for dermatologists.
    Scheinfeld N
    Dermatol Online J; 2006 May; 12(4):6. PubMed ID: 17083861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telavancin versus standard therapy for treatment of complicated skin and soft-tissue infections due to gram-positive bacteria.
    Stryjewski ME; O'Riordan WD; Lau WK; Pien FD; Dunbar LM; Vallee M; Fowler VG; Chu VH; Spencer E; Barriere SL; Kitt MM; Cabell CH; Corey GR;
    Clin Infect Dis; 2005 Jun; 40(11):1601-7. PubMed ID: 15889357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The practice guideline 'Bacterial skin infections' (first revision) from the Dutch College of General Practitioners; a response from the perspective of dermatology].
    Sanders CJ; Bruijnzeel-Koomen CA
    Ned Tijdschr Geneeskd; 2008 Jul; 152(29):1604-5. PubMed ID: 18998265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant Staphylococcus aureus.
    Elliott DJ; Zaoutis TE; Troxel AB; Loh A; Keren R
    Pediatrics; 2009 Jun; 123(6):e959-66. PubMed ID: 19470525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of linezolid versus vancomycin for hospitalized patients with complicated skin and soft-tissue infections in France.
    De Cock E; Sorensen S; Levrat F; Besnier JM; Dupon M; Guery B; Duttagupta S
    Med Mal Infect; 2009 May; 39(5):330-40. PubMed ID: 19304423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing incidence of methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: reconsideration of empiric antimicrobial therapy.
    Awad SS; Elhabash SI; Lee L; Farrow B; Berger DH
    Am J Surg; 2007 Nov; 194(5):606-10. PubMed ID: 17936421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daptomycin: first in a new class of antibiotics for complicated skin and soft-tissue infections.
    Kern WV
    Int J Clin Pract; 2006 Mar; 60(3):370-8. PubMed ID: 16494659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complicated skin and soft tissue infection.
    Dryden MS
    J Antimicrob Chemother; 2010 Nov; 65 Suppl 3():iii35-44. PubMed ID: 20876627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin and soft tissue infection.
    Sharma S; Verma KK
    Indian J Pediatr; 2001 Jul; 68 Suppl 3():S46-50. PubMed ID: 11980459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on the management of skin, soft-tissue, and osteoarticular infections in children.
    Tien I
    Curr Opin Pediatr; 2006 Jun; 18(3):254-9. PubMed ID: 16721144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of linezolid in the treatment of complicated skin and soft tissue infections.
    Peppard WJ; Weigelt JA
    Expert Rev Anti Infect Ther; 2006 Jun; 4(3):357-66. PubMed ID: 16771613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diabetic foot infections. Prevalence and antibiotic sensitivity of the causative microorganisms].
    Martínez-Gómez Dde A; Ramírez-Almagro C; Campillo-Soto A; Morales-Cuenca G; Pagán-Ortiz J; Aguayo-Albasini JL
    Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):317-21. PubMed ID: 19237227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin and soft tissue infection: microbiology and epidemiology.
    Dryden MS
    Int J Antimicrob Agents; 2009 Jul; 34 Suppl 1():S2-7. PubMed ID: 19560670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.